Emergent BioSolutions Inc 2022 SR
The report highlights Emergent's transition in a post-pandemic environment, focusing on its mission to protect and enhance life through medical countermeasures for threats like anthrax, smallpox, and opioid overdoses. Key achievements in 2022 include the acquisition of Tembexa and Ebanga, and the FDA priority review for over-the-counter NARCAN Nasal Spray. The company established a baseline for Scope 1 and 2 greenhouse gas emissions and reported a total recordable incident rate of 0.76. Additionally, Emergent expanded its corporate social responsibility program, Emergent GIVES, and maintained a diverse workforce with 48.3% global gender diversity.
Company: Emergent BioSolutions Inc
Sector: Manufacturing
Country: United States
Year: 2022
Type: SR
Pages: 46
Back to company
Emergent BioSolutions Inc
ESG Report
The report highlights Emergent's transition in a post-pandemic environment, focusing on its mission to protect and enhance life through medical countermeasures for threats like anthrax, smallpox, and opioid overdoses. Key achievements in 2022 include the acquisition of Tembexa and Ebanga, and the FDA priority review for over-the-counter NARCAN Nasal Spray. The company established a baseline for Scope 1 and 2 greenhouse gas emissions and reported a total recordable incident rate of 0.76. Additionally, Emergent expanded its corporate social responsibility program, Emergent GIVES, and maintained a diverse workforce with 48.3% global gender diversity.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
Oct 30, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Employees